In a subset of inherited retinal degenerations (including cone, cone-rod, and macular dystrophies), cone photoreceptors are more severely affected than rods; ABCA4 mutations are the most common cause of this heterogeneous class of disorders. To identify retinal-disease-associated genes, we performed exome sequencing in 28 individuals with ''cone-first'' retinal disease and clinical features atypical for ABCA4 retinopathy. We then conducted a gene-based case-control association study with an internal exome data set as the control group. TTLL5, encoding a tubulin glutamylase, was highlighted as the most likely disease-associated gene; 2 of 28 affected subjects harbored presumed loss-of-function variants: c. . We then inspected previously collected exome sequence data from individuals with related phenotypes and found two siblings with homozygous nonsense variant c.1627G>T (p.Glu543*) in TTLL5. Subsequently, we tested a panel of 55 probands with retinal dystrophy for TTLL5 mutations; one proband had a homozygous missense change (c.1627G>A [p.Glu543Lys]). The retinal phenotype was highly similar in three of four families; the sibling pair had a more severe, early-onset disease. In human and murine retinae, TTLL5 localized to the centrioles at the base of the connecting cilium. TTLL5 has been previously reported to be essential for the correct function of sperm flagella in mice and play a role in polyglutamylation of primary cilia in vitro. Notably, genes involved in the polyglutamylation and deglutamylation of tubulin have been associated with photoreceptor degeneration in mice. The electrophysiological and fundus autofluorescence imaging presented here should facilitate the molecular diagnosis in further families.
Retinal dystrophies are a clinically and genetically diverse group of inherited disorders that feature loss or dysfunction of photoreceptor cells as a primary or secondary event.
1 Thorough structural and functional assessment of the retina can be performed with the use of optical coherence tomography, 2 fundus autofluorescence imaging, 3 and visual electrophysiology. 4, 5 The latter is critical to the accurate diagnosis of retinal dystrophies and can reveal the degree of associated cone and rod photoreceptor dysfunction. Disorders in which the cone photoreceptors are more severely affected than rods include cone and conerod dystrophies (central-and usually peripheral-cone involvement) and macular dystrophies (central-cone involvement). These disorders show clinical overlap, and central visual loss in the first decades of life is a common symptom. Genetic overlap is also observed; recessive mutations in ABCA4 (MIM 601691) are by far the most common cause of both cone-rod and macular dystrophy. 6,7 ABCA4
retinopathy exhibits extensive clinical heterogeneity, but despite the range of phenotypes, the majority of affected individuals have suggestive features on fundus examination. These include yellow-white retinal flecks and/or sparing of retinal tissue around the optic disc (''peripapillary sparing''). It is easier to detect these abnormalities on fundus autofluorescence imaging, a noninvasive imaging modality that uses naturally occurring fluorescence from the retina to provide functional information about retinal cells. 3 In order to gain insights into the molecular pathology of retinal dystrophies, we recruited 28 families from the inherited-retinal-disease clinics at Moorfields Eye Hospital in London (Table S1 , available online). Inclusion criteria were (1) a retinal dystrophy phenotype with early cone photoreceptor involvement, (2) an unknown molecular diagnosis after previous genetic screening or no previous genetic testing, and (3) an absence of fundoscopic and fundus autofluorescence imaging suggestive of ABCA4-associated retinopathy. Data from a representative set of 22 of the 28 probands are presented in Figures 1A, 1B , and S1, which show a common phenotype regarding retinal topography on fundus autofluorescence imaging. The study was approved by the local ethics committee, and all investigations were conducted in accordance with the principles of the Declaration of Helsinki; informed consent was obtained from all study participants.
DNA samples were collected and analyzed by highthroughput sequencing (exon capture by SureSelectXT Human All Exon V5, Agilent; sequencing by HiSeq2000, Illumina). To rank genes and prioritize follow-up, we then performed a gene-based case-control association study. This case-control approach compares the number of rare potentially deleterious alleles between case and control groups, hence making no specific assumption about the mode of inheritance (dominant or recessive); although more powerful models could be used if the inheritance model were known, the lack of information motivated this choice. The control samples (''UCL-exomes samples'') were collected by a research consortium based in the UK and, in particular, by University College London. This consortium was designed to share raw read-level data from multiple exome sequencing projects in order to facilitate case-control association studies.
Case-control comparison using calls generated from shortread high-throughput DNA sequencing is complicated by the nonnegligible frequency of variant-calling inaccuracies that result from limitations of existing technologies. This issue is compounded by the heterogeneity of sequence-capture kits (especially for the diverse UCL-exomes collection of control samples) and variant calling. As an example, such a technical issue arose for TTLL5 in the context of our comparison with the NHLBI Exome Sequencing Project Exome Variant Server (EVS, see below). To mitigate this problem, we used a multisample sequence-variant-calling strategy, including BAM file compression of redundant sequencing reads, 8 for the 28 probands and 1,750 internal control samples on the basis of the Genome Analysis Toolkit guidelines (GATK version 2.7.4, Broad Institute). 9 The variant-quality recalibration steps recommended by the GATK best practices were applied. Candidate variants were further filtered with ANNOVAR (OpenBioinformatics) 10 on the basis of putative effect on protein and/or mRNA (presumed loss-of-function, nonsynonymous, and splice-altering changes were selected; Ensembl gene and transcript annotations were used). Gene-based p values were computed with two strategies: a binomial test for excess of rare variants in the case group and the more general gene-based testing procedure Sequence Kernel Association Test (SKAT). 11 In order to use the UCL-exomes control samples, (1) we inferred ancestry on the basis of the exome sequencing data, and using a principal-component analysis, we excluded samples that did not cluster with the bulk of the UCL-exomes samples, which are predominantly of European origin ( Figure 2A ; 5 out of 28 case samples were also removed); (2) we removed all samples with a history of retinal disease; and (3) when several samples were sequenced in a family, we kept a single sample per family to obtain unrelated control samples. After these exclusion steps, 1,465 control samples were left. For our binomial testing approach, it has been previously highlighted that association tests are biased when the same control cohort is also used for defining a minor-allele-frequency (MAF) threshold to flag candidate variants. 12 To address this issue while still taking advantage of our technically and ethnically matched control samples, we divided the remaining 1,465 control samples into two subsets. The first subset included 25% of the samples (n ¼ 366) and was used for defining a MAF threshold; a MAF < 0.3% (i.e., no more than two occurrences of the rare allele in 366 control samples) was utilized. The NHLBI Exome Sequencing Project EVS was also used for filtering rare candidate variants (with a frequency threshold of 0.1%). The second subset included the remaining 1,099 UCL-exomes control samples and was used directly for generating gene-based case-control binomial-test association statistics. This splitting of the control data set was not relevant for the SKAT gene-based testing.
The result of this genome-wide scan is shown in Figure 2B (for presumed loss-of-function variants) and Figure 2C (for nonsynonymous and splice-altering rare variants). Table 1 shows the list of autosomal genes ranked on the basis of the gene-based binomial p values that test for an excess of presumed loss-of-function candidate variants in case samples. Table S2 shows the larger set of nonsynonymous (including presumed loss-of-function) and splicealtering variants. The loss-of-function analysis flagged two hemizygous disease-causing variants in RPGR (MIM 300029), a gene previously associated with X-linked retinal dystrophy, and one homozygous presumed loss-offunction variant in another retinal-disease-related gene, CDH3 (MIM 114021; Table S1 ).
The most significant gene-based p value was obtained for TTLL5 (MIM 612268, RefSeq accession number NM_015072.4), a gene encoding tubulin tyrosine ligaselike family, member 5 (Tables 1 and S2 ). Two of 28 probands were found to harbor a pair of presumed loss-of-function 
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Genes are ranked on the basis of the binomial p value test, which tests for equal proportion of presumed loss-of-function rare variants between case and control groups against the alternative of an excess of the same class of variants in the case group. To define ''rare'' variants, we utilized two cohorts: a subset of 25% of UCLexomes control samples (366 unrelated samples, randomly sampled and not included directly in the case-control analysis; MAF < 0.3% was used) and the NHLBI Exome Sequencing Project EVS (MAF < 0.1% was used). The following abbreviation is used: Chr, chromosome. a The 28 probands had (1) retinal dystrophy with early cone photoreceptor involvement, (2) an unknown molecular diagnosis after previous genetic screening or no previous genetic testing, and (3) an absence of fundoscopic and fundus autofluorescence imaging suggestive of ABCA4 retinopathy. Five of these 28 subjects were excluded on the basis of ancestry (Figure 2A ). b The 1,750 control samples were analyzed with the same sequence-variant-calling strategy as the 28 retinal dystrophy probands. After (1) inferring ancestry on the basis of the exome sequencing data and using a principal-component analysis to exclude samples that did not cluster with the bulk of the UCL-exomes samples (which are predominantly of European origin; Figure 2A ), (2) removing all samples with a history of retinal disease, and (3) excluding related control samples, we were left with 1,465 unrelated control samples.
variants in this gene. Subject CD1 (IV1, family gc18728 in Figure 3 ), a 38-year-old man born to consanguineous parents, had a homozygous 4 bp deletion (c.1586_ 1589delAGAG [p.Glu529Valfs*2]). Furthermore, subject CD2 (IV:6, family gc19552 in Figure 3 ), a 45-year-old male with a very similar phenotype (Figures 1A and 1B ; In addition to data from this cohort of 28 affected subjects with homogeneous clinical presentation, exome sequencing data from 63 molecularly unsolved families with retinal dystrophies were generated as part of an ongoing project at Moorfields Eye Hospital. The clinical diagnoses in these families were cone-rod dystrophy (n ¼ 4), cone dystrophy (n ¼ 3), macular dystrophy (n ¼ 20), rodcone dystrophy (n ¼ 8 nonsyndromic and 11 syndromic), early-onset retinal dystrophy (n ¼ 9), and Leber congenital amaurosis (n ¼ 8). We reviewed the exome sequencing data from these families with the aim of identifying additional individuals with most likely disease-causing variants in TTLL5; a 44-year-old man (subject CD3; III:4, family gc16138 in Figure 3 ) with an early-onset cone-rod dystrophy phenotype ( Figure 1C ; Figure 3 ) with the same genotype (Table S3 ). An unaffected sibling was heterozygous for the mutation. Subsequently, 55 additional probands with ''cone-first'' retinal dystrophy were ascertained and tested for mutations in TTLL5 by Sanger sequencing of the coding region and intron-exon boundaries of the gene (primers and conditions are provided in Table S4 ). A 53-year-old man (subject CD5; II:1, family gc19420 in Figure 3 ) with an adultonset cone dystrophy phenotype had a homozygous missense change (c.1627G>A [p.Glu543Lys]); this sequence alteration affects the same amino acid that is altered in the sibling pair of subjects CD3 and CD4.
Overall, four families affected by retinal dystrophy and most likely disease-causing variants in TTLL5 were identified. Two frameshift (p.Leu134Argfs*45 and p.Glu529Valfs*2), two nonsense (p.Glu543* and p.Trp1118*), and one missense (p.Glu543Lys) change altering an amino acid conserved in all vertebrates ( Figure S2 ) were found. In contrast, only five presumed loss-of-function variants were present in 1,465 unrelated UCL-exomes control samples (Table S5) . In order to estimate the prevalence of disease caused by biallelic TTLL5 variants, we investigated the frequency of presumed lossof-function alleles in a larger data set of 26,000 exomes assembled from a variety of complex-disease-sequencing consortia at the Broad Institute of Harvard and MIT in Boston. The Broad 26K exome data set includes the widely used NHLBI Exome Sequencing Project EVS but was reanalyzed with an optimized joint calling strategy similar to the one applied to UCL-exomes. 9 Interestingly, two relatively common frameshift indels (up to 0.5% allele frequency) are listed in the NHLBI EVS. Excess of homozygous calls for these variants points to false-positive calls, and indeed, the optimized multisample calling approach excluded these calls as artifacts. Overall, the estimated frequency of presumed loss-of-function variants in the 26,000 exomes of the Broad 26K data set was 0.09% (Table S5 ), a number not statistically different (p > 0.05) from the frequency estimate in the smaller UCL-exomes control cohort (0.17%).
The clinical and electrophysiological phenotype in three of four families affected by TTLL5-related disease was almost identical: subjects CD1, CD2, and CD5 had central and peripheral cone dysfunction with preservation of rod photoreceptor function on electrophysiology ( Figure 4 ; Table 2 ) and a similar appearance on fundus autofluorescence imaging ( Figures 1A, 1B, and 1D ). In contrast, the sibling pair of subjects CD3 and CD4 had a more severe phenotype with poor vision from the first years of life, severe generalized cone-system dysfunction, and additional significant involvement of rod photoreceptors (Figures 1C and 4 ; Table 2 ). This clinical heterogeneity cannot be easily explained by the TTLL5 genotype; notably, subject CD1 had presumed loss-of-function variants earlier in the protein than did subjects CD3 and CD4 (p.[Glu529Valfs*2]; [Glu529Valfs*2]) and p.[Glu543*];[Glu543*], respectively).
TTLL5 is a 32-exon gene with high expression in heart and skeletal muscle and lower expression in many other tissues, including the eye (Unigene) and brain. 13, 14 It encodes a 1,281 amino acid protein that is localized to the cytoplasm and nucleus. 13 This protein is the largest of 13 members of the tubulin tyrosine ligase-like (TTLL) superfamily and contains the highly homologous core tubulin tyrosine ligase domain in its N terminus. In addition, TTLL5 has a C-terminal coactivator-interaction domain and three C-terminal receptor-interaction domains. 15, 16 Multiple activities have been implicated for TTLL5. First, it is thought to play an important role in the polyglutamylation of primary cilia. 17, 18 Polyglutamylation is a posttranslation modification associated with sequential attachment of glutamic acids (up to 20 units) to an internal glutamate residue of the target protein. 19, 20 The main target of polyglutamylation is thought to be the glutamate-rich C terminus of tubulins (building blocks of microtubules), 21 and TTLL5 is thought to be a key initiator of polyglutamylation in a-tubulin. 17 Second, TTLL5 has been found to be essential for the correct function of sperm flagella. 16 Mutant mice that retain the TTLL domain but lack the C-terminal extension that is thought to be responsible for a variety of transcriptional cofactor activities (including glucocortocoid-mediated gene induction) 13, 22 have been previously generated. 16 These mice (Stamp tm/tm ), despite having either no TTLL5 or markedly reduced levels of a prematurely terminated protein (roughly half TTLL5 will be missing), only demonstrate a sex-dependent effect on fertility. Female mice are normal, whereas male mice are infertile and have defective sperm structure and motility. 16 Third and finally, a recent study has shown that TTLL5 has no unique function for ciliary stability or beating in brain ependymal cilia. 14 The tubulin tyrosine ligase domain in human TTLL5 is predicted to be between amino acids 62 and 407 (UniProt). It has been shown in other TTLLs that added sequences of 100-150 amino acids on either side of the core tubulin tyrosine ligase domain are required for full polyglutamylation activity. 23 Thus, it can be speculated that four (p.Leu134Argfs*45, p.Glu529Valfs*2, p.Glu543*, and would be expected to have a molecular defect similar to that of the Stamp tm/tm mice. It is therefore of interest that subject CD3 has two unaffected children (Figure 3 ; paternity has not been confirmed). Analysis of the sperm from affected individuals might provide further insights. It is not clear how defects in TTLL5 can cause centraland peripheral-cone dysfunction. It has been previously reported that defects in fleer, a regulator of tubulin glutamylation and glycylation of cilia microtubules, result in photoreceptor outer-segment defects in zebrafish. 24, 25 Furthermore, mice lacking one of the enzymes that catalyze deglutamylation of a-tubulin (Agtpbp1 pcd mutant mice), an essential subunit of cilia microtubules, have been shown to have retinal degeneration. 26, 27 Interestingly, around 25% of previously reported retinal-dystrophy-related genes are associated with the structure or function of the photoreceptor connecting cilium, a specialized nonmotile primary sensory cilium that represents the light-sensitive Table 2 for further explanation.
outer segments. 1, 28 Additionally, although polyglutamylation was initially considered a tubulin-specific modification, it is now well recognized as a much more widespread posttranslational modification. 17 Further experiments using proteomic approaches might demonstrate new substrates for polyglutamylation in the retina.
To study the localization of TTLL5 in the retina, we stained a donor human retina from a 56-year-old healthy individual (from the Department of Ophthalmology, University of Mainz [Germany] ) and cryofixed BI6 mouse eye sections with TTLL5 antibodies as previously described.
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TTLL5 was detected in rod and cone photoreceptors of mouse and human retinae; in the human retina, TTLL5 staining was more prominent in cones ( Figure 5 ). Furthermore, TTLL5 localized to the base of the connecting cilium between the basal body (mother centriole) and the adjacent daughter centriole of the cilium. There, TTLL5 might be responsible for the tubulin polyglutamination in the microtubule triplets of the centrioles, increasing the centriole stability, as previously reported. 30 Notably, as in other primary cilia, the periciliary region of the photoreceptor cilium harbors the molecular modules for the regulation of delivery into the ciliary compartment, namely the connecting cilium (transition zone) and the photosensitive outer segment. 31, 32 It is worthy of speculation that polyglutamylation of tubulin molecules destined for the cilium might occur in this strategic site at the base of the cilium. In any case, the microtubules of the photoreceptor cilia apparatus are stabilized against mechanical forces. Given that cones are characterized by open membrane disks lacking the complete sheath of the plasma membrane present in rods, the absence of TTLL5, which should result in the destabilization of the microtubule cytoskeleton of photoreceptor cells, might affect the maintenance of cones more than rods. In the periciliary compartment, the products of other ciliopathy genes can be found. [33] [34] [35] [36] [37] We have shown that TTLL5, encoding a member of the TTLL superfamily, is associated with human disease. Other genes encoding members of the TTLL family have been shown to cause a variety of disorders in animal models; these include primary ciliary dyskinesia in Ttll1 mutant mice 38 and defective olfactory cilia structures in ttll6 mutant zebrafish. 24, 25 The human phenotype observed in the present study would be consistent with some degree of functional redundancy among some of these glutamylating enzymes in humans.
To date, mutations in over 200 genes have been shown to cause retinal degeneration (Retinal Information Network, see Web Resources). The identification of genes associated with these disorders is a major challenge, particularly because they are likely to be less prevalent and less obvious candidates than those already known. We have performed exome sequencing in 28 individuals with a similar disease phenotype and subsequently used a casecontrol approach to identify mutations in TTLL5 as a cause of recessive retinal dystrophy. This powerful approach facilitates the identification of disease-causing alleles among the background of nonpathogenic genomic variation and sequencing errors. Overall, three families affected by presumed loss-of-function variants and one proband with a homozygous missense change were identified. The electrophysiological and fundus autofluorescence imaging reported in the present series should hopefully facilitate the identification of further families.
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